Glasgow-based Northern Light Microscopy (NLM), a University of Strathclyde spinout, has closed an oversubscribed £1 million pre-seed round to bring its compact super-resolution imaging system to market — backing a Scottish technology that could meaningfully lower the cost barrier for advanced microscopy across the global life sciences industry.
The round, announced on 22 April 2026, was led by DSW Ventures, with participation from Scottish Enterprise, SWIM Capital and the University of Strathclyde through the Strathclyde Inspire Entrepreneurs Fund. The investment will scale production of NLM’s flagship Advanced Modular Imaging System (AMIS) and fund continued software development ahead of first commercial sales.
The Problem NLM Is Solving
Super-resolution microscopy — the ability to capture imaging detail beyond the diffraction limit of traditional light microscopes — is a critical tool underpinning research across bioscience, biotech and pharma. But existing systems are expensive, technically complex and difficult to integrate into existing lab workflows. The practical consequence: thousands of labs worldwide are effectively priced out of the technology, limiting both the volume and the resolution of bioscience discoveries.
NLM was set up specifically to break that barrier. Its AMIS product is a compact, benchtop system combining proprietary micro-optics with structured illumination techniques to deliver up to eight imaging modes in a single, cost-effective instrument — without requiring researchers to change their existing protocols.
What Sets the Technology Apart
At the heart of AMIS sits NLM’s proprietary micro-optical light engine, which gives users illumination control across multiple wavelengths and magnifications. The system pairs high-throughput imaging with super-resolution capability and has already outperformed established systems costing significantly more in direct comparison studies.
The investment will fund three priorities:
- Production scale-up for early commercial deployments
- Continued development of LINK, NLM’s imaging software
- Hardware module expansion and additional product lines
The company is targeting UKCA and CE marking ahead of first commercial sales. Early customer deployments will inform product development through 2026, with international expansion planned from 2027.
The Team Behind It
NLM was co-founded by Dr Peter Tinning (CEO) and Dr Ralf Bauer (CTO), both with deep technical roots at the University of Strathclyde. The company is a member of the Roslin Innovation Centre, giving it access to one of the UK’s most active life sciences innovation campuses.
Dr Tinning said: “We’re excited to enter the next stage for Northern Light Microscopy. With the technology validated, this funding enables us to move forward into initial sales, scaling and product line expansion.
“It’s been great to work with both new investors like DSW Ventures, Scottish Enterprise, and SWIM Capital, alongside the continued support from the University of Strathclyde, who recognise both the strength of the technology and our ability as founders to build a commercially viable business. We’re lucky to benefit from such a strong support system for spinouts here in Scotland as we bring AMIS to market.”
Why the Investors Backed It
James Reston, Investment Manager at DSW Ventures, said: “Northern Light Microscopy has developed an instrument that delivers super-resolution imaging performance at a price point that opens the technology to thousands of laboratories currently priced out of advanced microscopy.
“The AMIS has already outperformed established systems costing significantly more in direct comparison studies, and Peter and Ralf bring a combination of deep technical expertise and commercial understanding that gives us confidence in the company’s ability to execute on its commercial plan. We look forward to supporting the team as they bring the AMIS to market.”
Anne Henderson, Head of Investment at the University of Strathclyde, said: “Northern Light Microscopy is a great example of a Strathclyde spinout with a clear commercial plan, an experienced founding team, and genuinely differentiated technology. We are delighted to have supported the company through the Strathclyde Inspire Entrepreneurs Fund and look forward to seeing the team bring AMIS to market.”
What It Says About Scotland’s Deep-Tech Pipeline
NLM is one of a growing cohort of Scottish university spinouts attracting institutional pre-seed and seed capital in 2026. The deal sits alongside a broader picture of Scottish tech momentum — new Scottish tech company formations surged 70% year-on-year in Q1 2026 according to RSM UK, while growth-stage capital continues to flow into Scottish companies across sectors, as demonstrated by Edinburgh’s Esk Film Services securing £2.6m from Maven Capital Partners to scale its live entertainment technology platform worldwide.
For Strathclyde and for Glasgow’s photonics and life sciences ecosystem more broadly, NLM adds further weight to the city’s positioning as a UK hub for deep-tech commercialisation — and if AMIS performs commercially the way it has in comparison studies, this £1m pre-seed could prove to be one of the more strategically significant Scottish deep-tech bets of 2026.
